• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Fluor Corporation (Amendment)

    2/9/24 9:03:05 AM ET
    $FLR
    Military/Government/Technical
    Industrials
    Get the next $FLR alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.3 FLUOR CORP NEW COMMON STOCK Cusip #343412102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #343412102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 13,546,628 Item 6: 0 Item 7: 13,559,609 Item 8: 0 Item 9: 13,559,609 Item 11: 7.948% Item 12: HC Cusip #343412102 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 13,559,609 Item 8: 0 Item 9: 13,559,609 Item 11: 7.948% Item 12: IN Item 1(a). Name of Issuer: FLUOR CORP NEW Item 1(b). Address of Issuer's Principal Executive Offices: 6700 Las Colinas Blvd Irving, TX 75039 Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 343412102 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 13,559,609 (b) Percent of Class: 7.948% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 13,559,609 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of FLUOR CORP NEW. No one other person's interest in the COMMON STOCK of FLUOR CORP NEW is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company BK Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of FLUOR CORP NEW at December 29, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $FLR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FLR

    DatePrice TargetRatingAnalyst
    12/18/2024$54.00 → $58.00Outperform → Neutral
    Robert W. Baird
    10/22/2024$52.00 → $65.00Neutral → Buy
    Citigroup
    7/17/2024$57.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/14/2024$46.00Buy
    Truist
    1/10/2024Sector Weight
    KeyBanc Capital Markets
    10/4/2023$35.00 → $47.00Neutral → Buy
    UBS
    11/7/2022$25.00 → $40.00Neutral → Buy
    DA Davidson
    2/23/2022$30.00 → $29.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $FLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Fluor downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Fluor from Outperform to Neutral and set a new price target of $58.00 from $54.00 previously

      12/18/24 7:34:35 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor upgraded by Citigroup with a new price target

      Citigroup upgraded Fluor from Neutral to Buy and set a new price target of $65.00 from $52.00 previously

      10/22/24 6:16:21 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Fluor from Sector Weight to Overweight and set a new price target of $57.00

      7/17/24 7:35:40 AM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chairman Constable David E sold $2,005,972 worth of shares (40,000 units at $50.15), decreasing direct ownership by 5% to 830,627 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/17/25 4:30:21 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Executive Chairman Constable David E sold $1,999,343 worth of shares (40,800 units at $49.00), decreasing direct ownership by 4% to 870,627 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/12/25 5:49:22 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • GROUP PRESIDENT Collins Alvin C Iii sold $859,536 worth of shares (18,920 units at $45.43), decreasing direct ownership by 23% to 64,383 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/10/25 4:53:26 PM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification

      Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs Fluor Corporation (NYSE:FLR) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519864245/en/Bayer's Cell T

      5/19/25 7:19:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor Reports First Quarter 2025 Results

      "Grow and execute" chapter of Fluor's strategy launched Q1 revenue book to burn ratio of 1.5x Accelerated Q1 share repurchases of $142 million; targeting $600 million in repurchases for 2025 Company maintains 2025 guidance Fluor Corporation (NYSE:FLR) announced financial results for its first quarter ended March 31, 2025. "We are well positioned for the grow and execute chapter of our Building a Better Future strategy. As we continue to deliver on our projects and take in quality backlog, we see substantial opportunities for growth in our key markets. Our businesses are focused on organic growth and our core competencies will deliver results that support our customers' needs," sai

      5/2/25 5:50:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor to Participate in Upcoming Investor Conferences

      Fluor Corporation (NYSE:FLR) announced today that management will be hosting one on one meetings at the following conferences for the second quarter of 2025: May 8: Truist Securities Industrials & Services Conference – John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. May 28: KeyBanc Industrials & Basic Materials Conference - Jim Breuer, Chief Executive Officer will be joining John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. June 4: Baird Global Consumer, Technology & Services Conference – Steve Hopkins, Sr. Vice President of Advanced Technologies & Life Sciences will be joining Jason Landkamer, Vic

      4/30/25 8:00:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    SEC Filings

    See more
    • Fluor Corporation filed SEC Form 8-K: Leadership Update

      8-K - FLUOR CORP (0001124198) (Filer)

      6/24/25 5:04:39 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • SEC Form SD filed by Fluor Corporation

      SD - FLUOR CORP (0001124198) (Filer)

      6/2/25 4:34:19 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Fluor Corporation

      SCHEDULE 13G/A - FLUOR CORP (0001124198) (Subject)

      5/12/25 10:44:45 AM ET
      $FLR
      Military/Government/Technical
      Industrials